Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-11-23
2000-05-23
Crouch, Deborah
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514895, 4353201, 935 65, A61K 4800, C12N 500, C12N 1500
Patent
active
060666234
ABSTRACT:
A first embodiment is a specific plasmid vector, pDIP/PyCSP.1, into which nucleotides encoding the targets of specific immune responses are inserted. These targets include, but are not limited to proteins and peptides. These plasmid constructs are incorporated in a composition comprising a suitable and acceptable art recognized pharmaceutical reagent that is benign (non-reactive with) to the plasmid construct. The plasmid construct provides protective immune responses to the disease associated with the selected targets. A second embodiment is a construct having, at a minimum, the nucleotide sequences encoding one or more Plasmodium species proteins in a pharmaceutically acceptable vector. a third embodiment is a method of controlling malaria in mammals comprising injecting a polynucleotide delivery vector into a mammal.
REFERENCES:
Bryan Rd. Cullen, Cell, vol. 46, pp. 973-982, Sep. 26, 1986.
Hoffman et al., Preerythrocytic Malaria Vaccine Development*, Job PACKBJ 8$$$$28 Galley--05-07-93 08-07-01.
Ulmer et al., Science, vol. 259, pp.1745-1749, Mar. 19, 1993.
Robinson et al (1992) Modern Approaches to Vaccines, Including Prevention of Aids, Cold Spring Harbor, 92. Caspers et al (1989) Molec. Biochem Paraset. 35, 185-190.
Lal et al (1987) J. Biol. Chem. 262, 2937-2940.
Good et al (1987) Nature 235, 1059-1062.
Ostro et al (1989) Am. J. Hospt. Pharm. 46, 1576-1587.
Arnott et al(1985) Science 230, 815-818.
Wolff et al (1990) Science 247, 1465-1468.
Lal et al (1988) Molec. Biochem. Parasit. 30, 291-294.
Fasel et al (1992) Gene 111, 157-163.
Young et al (1985) Science 228, 958-962.
Caspeb et al (1989) Molec. Biochem. Parasit. 35, 185-190.
Hedstrom Richard C.
Hoffman Stephen L.
Sedegah Martha
Crouch Deborah
Spevack A. D.
The United States of America as represented by the Secretary of
LandOfFree
Polynucleotide vaccine protective against malaria, methods of pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polynucleotide vaccine protective against malaria, methods of pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotide vaccine protective against malaria, methods of pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1837213